Press releases -Antibiotice

2024

Press release financial results of the first semester of 2024

Antibiotice Iasi invests in digitalization for the transition to a sustainable business

The Antibiotice Iași business growth by 24% in 2023 strengthens the company’s development

Antibiotice Iasi has commissioned a 2.5 MW photovoltaic plant, financed by the RRRP, which will provide over 25% of the electricity requirements

2023

First InvestEU agreement in Romania provides €25 million in EIB financing to boost security of supply for medicines

Antibiotice Iași Wins a New Tender Launched by the National Health Service of the United Kingdom

The economic and financial results recorded in 2022

The European Investment Bank and Antibiotice SA signed an advisory service agreement for the strategic development of the industrial site of the company

2020

Press release – Antibiotice SA won EU auction for the antibiotic AmoxiPlus®

Press release – Financial results at 6 months (14.08.2020)

2019

Q3 Financial results (11.15.2019)

Q2 Financial results

The main decisions of the General Meeting of the Shareholders of the Antibiotic company, held today, April 18, 2019

2018

Financial results for 9 months 2018 (14.11)

Press release – Antibiotics of the Third Millennium – debate with international participation

Press release – Preliminary financial results 2017 (15.02)

Press Releases – Financial Results 2017 – OGMS Decisions (26.04)

Press release – Financial results at 6 months (14.08)